X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes

scientific article published on 15 May 2015

X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1051312367
P356DOI10.1186/S12943-015-0369-2
P932PMC publication ID4431032
P698PubMed publication ID25971982
P5875ResearchGate publication ID276308856

P2093author name stringSeung Won Shin
Joo Young Lee
Jung Eun Koo
Soong Ho Um
P2860cites workThe effects of TLR activation on T-cell development and differentiationQ27001581
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsQ27860900
Cancer immunoediting: from immunosurveillance to tumor escapeQ28212251
Interferons at age 50: past, current and future impact on biomedicineQ28259312
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsQ29615665
Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cellsQ30179408
Enzyme-catalysed assembly of DNA hydrogel.Q51129307
Malignancy after renal transplantationQ77440701
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotidesQ81474815
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceQ30436506
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.Q33211563
Human tumor xenograft models for preclinical assessment of anticancer drug developmentQ33554319
Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1Q34151749
The spontaneous regression of cancer. A review of cases from 1900 to 1987.Q34230803
Intracellular invasion of Orientia tsutsugamushi activates inflammasome in asc-dependent mannerQ34314100
Intrinsic and extrinsic regulation of innate immune receptorsQ35003295
Immunotherapeutic uses of CpG oligodeoxynucleotidesQ35730784
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.Q36757009
Toll-like receptor 9 (TLR9) agonists in the treatment of cancerQ37050998
The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis.Q37144338
Immune therapy for cancerQ37324793
Strange attractors: DAMPs and autophagy link tumor cell death and immunityQ37424115
Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acidsQ37664915
Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cellsQ39002621
PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cellsQ39017204
Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing miceQ39646708
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in miceQ39795607
Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formationQ40020895
Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotidesQ40376314
TLR9 signals after translocating from the ER to CpG DNA in the lysosomeQ40600429
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patientsQ41940744
Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factorQ45165652
Identification and distribution of the costimulatory receptor CD28 in the mouseQ46503670
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjecttoll-like receptorQ408004
inflammasome complexQ412405
colon cancerQ18555025
P304page(s)104
P577publication date2015-05-15
P1433published inMolecular CancerQ15724585
P1476titleX-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes
P478volume14

Reverse relations

cites work (P2860)
Q37596126CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
Q89736145DNA Nanostructure as an Efficient Drug Delivery Platform for Immunotherapy
Q49531599Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities
Q88727565Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure
Q92427012Hybrid material of structural DNA with inorganic compound: synthesis, applications, and perspective
Q97526934Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression
Q56594845Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics